The addition of new side chains created a socalled
second generation of cephalosporins with greater potency, especially against Gram-negative anaerobes. The third- and fourth-generation cephalosporins, synthesized with further modifi cations of the side chains, have a somewhat expanded spectrum of activity (see Fig. 5-5). Cephalosporins in this class have two important advantages: First, they extend the spectrum of activity to organisms that were resistant to most of the previous cephalosporins, including Pseudomonas, an opportunistic pathogen, and Haemophilus infl uenzae, an important pathogen in pulmonary infections and meningitis. Second, unlike the previous cephalosporins, they penetrate well into the central nervous system. This ability has made them especially useful in the treatment of Gram-negative meningitis. Like third- and fourth-generation cephalosporins, carbapenems typically have a very broad spectrum of activity, including most Gram-positive, Gram-negative, and anaerobic bacteria. The bactericidal action of the -lactam antibiotics requires the following steps: 1. Association with the bacteria 2. Penetration through the outer membrane and the periplasmic space (only in Gram-negatives) 3. Interaction with penicillin-binding proteins (PBPs) on the cytoplasmic membrane 4. Activation of an autolysin that degrades the cell wall murein The principal mechanism of resistance to the -lactams is the elaboration of inactivating enzymes, the b-lactamases. So far, more than 300 -lactamases have been identifi ed, a small number of which account for most of the clinically encountered resistance. They can be divided into major categories, including the penicillinase, cephalosporinases, extended-spectrum beta-lactamases or ESBLs (which confer